Clearside Biomedical, Inc. (CLSD) Deferred Tax Assets, Valuation Allowance USD 2014 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Clearside Biomedical, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2014 to 2023.
  • Clearside Biomedical, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $84 M, a 14% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $84 M +$10.3 M +14% Dec 31, 2023 10-K 2024-03-12
Q4 2022 $73.7 M +$7.1 M +10.7% Dec 31, 2022 10-K 2024-03-12
Q4 2021 $66.6 M +$3.2 M +5.04% Dec 31, 2021 10-K 2024-03-12
Q4 2020 $63.4 M +$7.2 M +12.8% Dec 31, 2020 10-K 2023-03-14
Q4 2019 $56.2 M +$6.64 M +13.4% Dec 31, 2019 10-K 2022-03-11
Q4 2018 $49.6 M +$16.9 M +51.7% Dec 31, 2018 10-K 2021-03-15
Q4 2017 $32.7 M +$7.22 M +28.4% Dec 31, 2017 10-K 2020-03-13
Q4 2016 $25.4 M +$9.84 M +63.1% Dec 31, 2016 10-K 2019-03-15
Q4 2015 $15.6 M +$11.4 M +272% Dec 31, 2015 10-K 2018-03-16
Q4 2014 $4.2 M Dec 31, 2014 10-K 2017-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.